Drug Profile
Sildenafil - Alvogen Korea
Alternative Names: KW 25084Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator KunWha Pharmaceutical
- Class Antihypertensives; Erectile dysfunction therapies; Phenyl ethers; Piperazines; Purines; Pyrazoles; Pyrimidinones; Small molecules; Sulfonamides
- Mechanism of Action Type 5 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Erectile dysfunction
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Erectile-dysfunction in Unknown (PO, Film)
- 03 Jun 2016 Chemical structure information added
- 01 Jun 2015 Phase-I clinical trials in Erectile dysfunction (PO) before June 2015